| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146661da348ab185cfd900580e2040f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b96216b36f3c4e0f16a9cf29f233c51 |
| publicationDate |
2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114007621-A |
| titleOfInvention |
JAK1 pathway inhibitors for the treatment of chronic lung allograft dysfunction |
| abstract |
The present disclosure relates to JAK1 pathway inhibitors and their use in the treatment of chronic lung allograft dysfunction, such as, for example, bronchiolitis obliterans syndrome. |
| priorityDate |
2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |